Pioneering Breakthroughs Together
Collaboration is the key to our success. We believe sharing knowledge and expertise are essential to rapidly bringing innovative therapies to patients. That’s why we are partnering with leading industry and academic institutions to launch the first platform trial for ALS and share information with our peers to accelerate therapeutic innovation. To join us, email HEALEYALSPlatform@mgh.harvard.edu.
Our commitment to advancing treatment and therapies for individuals with ALS encourages us to the constant pursuit of new research partnerships and collaborations. We look forward to sharing our progress as we work towards our goal: to find a cure for ALS. We can do this together!
Investigator ResourcesLearn more ways to partner with us in the collaborative HEALEY ALS Platform Trial.
HEALEY ALS Platform Trial Publication Policy
HEALEY ALS Platform Trial Ancillary Study Policy